Catalyst Brief

← Calendar

Readoutin 104d

Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. — quadrivalent recombinant norovirus vaccine (Pichia pastoris)

Phase 3 primary completion: Clinical Trial of Protective Efficacy of Quadrivalent Recombinant Norovirus Vaccine (Pichia Pastoris).

Date
Mar 2027
Type
Readout
Indication
Acute Gastroenteropathy Due to Norovirus

Source ↗Add to calendar

Get told when this date moves

The weekly brief is free. Pro adds reminders 7 days and 1 day before.